A study of magnitude and correlates of altered bone mineral density in type 2 diabetes mellitus patients of central rural India
Keywords:Bone mineral density, DEXA, Osteoporosis, Type II diabetes mellitus
Background: Diabetes mellitus is fast becoming the epidemic of the 21st century. It is a metabolic disease that affects multiple organ system in the body including bone metabolism and bone mass. There is high prevalence of decreased bone mineral density (BMD) in type 2 diabetes mellitus (T2DM) patients leading to osteoporosis, osteopenia and fracture. The aim of the present study was to find the magnitude and correlates of altered BMD in T2DM patients of central rural India.
Methods: This cross-sectional study was carried out at a tertiary care teaching hospital in central rural India from 2014 to 2016. It comprises of 200 T2DM patients with aged ≥35 years. Bone mineral density measurements were done by using peripheral dual energy X-ray absorptiometry (DEXA).
Results: Mean age of study subjects was 56.13±11.12 years with 43.5% males and 56.5% females. Our study results showed the magnitude of decreased BMD was 82%. 53% of the study subjects were osteoporotic and 29% were osteopenic. Significant associations were detected between decreased BMD and old age, female gender, high body mass index, high fasting blood sugar, high HbA1c and low serum calcium on multivariate analysis.
Conclusions: The prevalence of decreased BMD in patients with T2DM of central rural India is high, especially in females’ patients, obese patients, and uncontrolled diabetic patients. Awareness amongst the health care provider of this changes will directly affect the treatment decisions for patients, thereby preventing osteoporosis, osteopenia and mitigating potential fracture risk.
Joshi SR, Parikh RM. India-diabetes capital of the world: now heading towards hypertension. The J Association of Physicians of India. 2007;55:323-4.
Kumar A, Goel MK, Jain RB, Khanna P, Chaudhary V. India towards diabetes control: Key issues. The Australasian Med J. 2013;6(10):524-31.
Segen JC. Concise dictionary of modern medicine McGraw-Hill in New York; 2002.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Prac. 2010;87(1):4-14.
Johansson H, Oden A, Johnell O, Jonsson B, de Laet C, Oglesby A, et al. Optimization of BMD measurements to identify high risk groups for treatment--a test analysis. J Bone Miner Res. 2004;19(6):906-13.
Marshall D JO, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254-9.
Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA. 1992;268(23):3333-7.
Rishaug U, Birkeland KI, Falch JA, Vaaler S. Bone mass in non-insulin dependent diabetes mellitus. Scandinavian J Clinical Laboratory Investigation. 1995;55(3):257-62.
Stolk RP, Van Daele PL, Pols HA, Burger H, Hofman A, Birkenhager JC, et al. Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study. Bone. 1996;18(6):545-9.
Kamalanathan S, Nambiar V, Shivane V, Bandgar T, Menon P, Shah N. Bone mineral density and factors influencing it in Asian Indian population with type 2 diabetes mellitus. Indian J Endocrinol Metabol. 2014;18(6):831-7.
Leidig-Bruckner G, Grobholz S, Bruckner T, Scheidt-Nave C, Nawroth P, Schneider JG. Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus. BMC Endocrine Dis. 2014;14:33.
Maghbooli Z H-NA, Khoshniat M. A study of bone mineral density in diabetic patients. Iranain J Public Health. 2007;36(suppl):S37-S44.
Guven M CR, Tutus A. The evaluation of bone mineral Density in male and postmenopausal female patients with type 2 Diabetes Mellitus. Turk J Endocrinol Metab. 1999;4:169-72.
Wang XR PY. Correlation of bone mineral density with disease duration and body mass in elderly men with type 2 diabetes mellitus. J Clin Rehab Tissue Eng Res. 2008;15:2891–4.
Agarwal RP HM, Kochar A, Kochar DK. Evaluation of bone mineral density by osteosonography in patients with type 2 diabetes mellitus. JIACM. 2005;6:12935.
Dutta MK, Pakhetra R, Garg MK. Evaluation of bone mineral density in type 2 diabetes mellitus patients before and after treatment. Medical J Armed Forces India. 2012;68(1):48-52.
Gregson CL. ‘Friend or Foe’: high bone mineral density on routine bone density scanning (DXA), a review of causes and management. Rheumatology (Oxford). 2013;52(6):968-85.
Adil C, Aydın T, Taşpınar Ö, Kızıltan H, Eriş AH, Hocaoglu IT, et al. Bone mineral density evaluation of patients with type 2 diabetes mellitus. J Physical Therapy Sci. 2015;27(1):179-82.
Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, Addar M. Prevalence of osteoporosis among postmenopausal femaleswith diabetes mellitus. Saudi Med J. 2004;25(10):1423-7.
Fowell D MA, Powrie F, Dyke R, Mason D. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol Rev. 1991;123:37-64.
Krishnasamy S, Abell TL. Diabetic Gastroparesis: Principles and Current Trends in Management. Diabetes Ther. 2018;9(1):1-42.
Neil HA GW, Mather HM, Thompson AV, Thorogood M, Fowler GH, Hill RD, et al. The Oxford community Diabetes study; evidence for an increase in the prevalence of known diabetes in Great Britain. . Diabetic Med. 1987;4:539-43.
Alicja Milczarczyk1 EF. Osteoporosis and bone fractures in patients with diabetes mellitus. Diabet Dośw i Klin. 2008;8:63-7.
Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100(2):197-207.
Martin A, David V, Malaval L, Lafage-Proust MH, Vico L, Thomas T. Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway. Endocrinol. 2007;148(7):3419-25.
Hadzibegovic I, Miskic B, Cosic V, Prvulovic D, Bistrovic D. Increased bone mineral density in postmenopausal women with type 2 diabetes mellitus. Annals Saudi Med. 2008;28(2):102-4.
Dennison EM, Syddall HE, Aihie Sayer A, Craighead S, Phillips DI, Cooper C. Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study:evidence for an indirect effect of insulin resistance? Diabetologia. 2004;47(11):1963-8.
Cooper JA. The classic: fractures of the neck of the thigh-bone. Sir Astley BART, FRS, surgeon to the King. Clin Orthop Relat Res. 1973;92:3-5.
Baheiraei A, Pocock NA, Eisman JA, Nguyen ND, Nguyen TV. Bone mineral density, body mass index and cigarette smoking among Iranianwomen: implications for prevention. BMC Musculoskelet Disord. 2005;6:34.
Nguyen TV, Center JR, Eisman JA. Femoral neck bone loss predicts fracture risk independent of baseline BMD. J Bone Miner Res. 2005;20(7):1195-201.
Kahn A, Gibbons R, Perkins S, Gazit D. Age-related bone loss. A hypothesis and initial assessment in mice. Clin Orthopaed Rela Res. 1995(313):69-75.
Tung S, Iqbal J. Evolution, aging, and osteoporosis. Annals New York Acad Sciences. 2007;1116:499-506.
Majima T1 KY, Yamada T, Koike Y, Shigemoto M, Takagi C, Hatanaka I, et al. Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabeticpatients. Osteo Int Aug. 2005;16(8):907-13.
Faienza MF, Ventura A, Marzano F, Cavallo L. Postmenopausal osteoporosis: the role of immune system cells. Clinical Develop Immunol. 2013;2013.
Fawzy T, Muttappallymyalil J, Sreedharan J, Ahmed A, Alshamsi SO, AlAli MS, et al. Association between Body Mass Index and Bone Mineral Density in Patients Referred for Dual-Energy X-Ray Absorptiometry Scan in Ajman, UAE. J Osteoporosis. 2011:876309.
Wong Peter KK, Christie Jemma J, Wark John D. The effects of smoking on bone health. Clin Sci. 2007;113(5):233-41.
Oz SG, Guven GS, Kilicarslan A, Calik N, Beyazit Y, Sozen T. Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J National Med Associa. 2006;98(10):1598-604.
Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka-Czernik B, Feingold KR, et al. Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab. 2006;91(9):3349-54.
Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N England J Med. 2006;355(23):2427-43.
Komatsu Y, Majima T. Negative correlation between BMD and HbA1C in patients with type 2 diabetes. Clinical Calcium. 2006;16(8):1327-31.
Gregorio F, Cristallini S, Santeusanio F, Filipponi P, Fumelli P. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diab Res Clin Pract. 1994;23(1):43-54.
Wakasugi MWR, Tawata M, Gan N, Koizumi K, Onaya T. Bone mineral density measured by dual energy x-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone. 1993;14(1):29-33.
Takeda E, Yamamoto H, Yamanaka-Okumura H, Taketani Y. Increasing dietary phosphorus intake from food additives: potential for negative impact on bone health. Advances in nutrition (Bethesda, Md). 2014;5(1):92-7.